share_log

Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company

Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company

Reflect Scientific Inc. 解決了一家價值400億美元的生物製藥公司重新安排的冷凍櫃發貨事宜
GlobeNewswire ·  02/07 08:00

OREM, Utah, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in the development of ultra-low temperature storage solutions, today provided an update on the previously announced landmark order from a premier BioPharma company, valued at over $500,000. This notable agreement, the most significant single order in the Company's history, involves supplying our cutting-edge storage freezers to a BioPharma entity with a market capitalization of $40 billion.

猶他州奧勒姆,2024年2月7日(GLOBE NEWSWIRE)——超低溫存儲解決方案開發領域的領導者Reflect Scientific, Inc.(代碼:RSCF)今天提供了有關一家頂級生物製藥公司先前宣佈的價值超過50萬美元的具有里程碑意義的訂單的最新情況。這項值得注意的協議是公司歷史上最重要的單一訂單,涉及向一家市值爲400億美元的生物製藥實體提供我們的尖端儲存冰櫃。

Due to a short delay in the completion of a new facility for the customer, the delivery of the freezer shipment, initially scheduled for the end of the fourth quarter in 2023, has been rescheduled to the early second quarter of 2024. Reflect Scientific Inc. is committed to accommodating the needs of our clients while ensuring the delivery of our high-quality products within the newly agreed timeframe.

由於客戶新設施的完工出現短暫延遲,原定於2023年第四季度末交付的冷凍機已改期至2024年第二季度初。Reflect Scientific Inc. 致力於滿足客戶的需求,同時確保在新約定的時間範圍內交付我們的高質量產品。

Mr. Kim Boyce, CEO of Reflect Scientific Inc., stated, "Our dedication to meeting our clients' requirements, even in the face of scheduling adjustments, is paramount. We understand the complexities of our industry and are flexible in our approach to support our clients' success. This order exemplifies our commitment to providing top-tier cold storage solutions and reinforces our capability to manage and adapt to the dynamic needs of the BioPharma sector."

Reflect Scientific Inc. 首席執行官金·博伊斯表示:“即使面對日程調整,我們也致力於滿足客戶的要求至關重要。我們了解行業的複雜性,並靈活地支持客戶取得成功。該訂單體現了我們對提供頂級冷庫解決方案的承諾,並增強了我們管理和適應生物製藥行業動態需求的能力。”

Reflect Scientific Inc. continues to engage in discussions for several other contracts, with shipments slated for 2024, as part of our growth strategy and ongoing commitment to the BioPharma industry. We appreciate the continued trust and cooperation of our valued partners and remain focused on delivering innovative solutions that meet the critical storage needs of the BioPharma industry.

作爲我們增長戰略和對生物製藥行業的持續承諾的一部分,Reflect Scientific Inc.繼續討論其他幾份合同,定於2024年發貨。我們感謝我們重要合作伙伴的持續信任與合作,並將繼續專注於提供滿足生物製藥行業關鍵存儲需求的創新解決方案。

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn .

Reflect Scientific, Inc
Reflect Scientific, Inc. 總部位於猶他州奧勒姆,爲生物技術、製藥、醫療和運輸市場開發和銷售創新的低溫冷卻專有技術。Reflect Scientific的產品包括用於實驗室、運輸和計算機服務器機房的低溫冰櫃和冷藏系統。參觀 反射科學.com 以獲取更多信息。在推特 @ReflectSci 和 LinkedIn 上見我們 。

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."

前瞻性陳述
本新聞稿包含經修訂的1933年《證券法》第27A條和經修訂的1934年《證券交易法》第21E條所指的前瞻性陳述。前瞻性陳述不能保證未來的業績或業績,也不一定能準確表明在何時或之前實現此類業績或業績。前瞻性陳述基於發表聲明時獲得的信息,涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致我們的業績、活動水平、業績或成就與本新聞稿中前瞻性陳述所表達或暗示的信息存在重大差異。本新聞稿應根據場外交易市場集團有限責任公司交易代碼爲 “RSCF” 的公司文件中包含的披露內容以及其中引用並載於美國證券交易委員會埃德加檔案中 “披露” 標題下的公司先前相關文件中的披露,包括此類文件中列爲 “前瞻性陳述” 的披露。

CONTACT: Contact Investor Relations 801-607-1039 investor_relations@reflectscientific.com
聯繫人:聯繫投資者關係部 801-607-1039 investor_relations@reflectscientific.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論